Clean Science & Technology Ltd. · NSE:CLEAN
Clean Science & Technology — Q2 FY2023 Earnings Presentation
21 slides from Clean Science & Technology's earnings presentation, Oct 20, 2022
Slide 1: Cover letter to stock exchanges
20.10.2022 To, BSE Limited National Stock Exchange of India Limited Phiroze JeeJeebhoy Towers, Exchange Plaza, Plot no. C/1, Dalal Street, G Block, Bandra-Kurla Complex Fort, Mumbai – 400 001 Bandra (E), Scrip Code: 543318 Mumbai - 400 051 Trading Symbol: CLEAN Dear Sir/Madam, Subject: Investor Pres
Slide 2: Clean Science and Technology Ltd. Investor Presentation Q2 FY2023
Clean Science and Technology Ltd. Investor Presentation Q2 FY2023 I October 2022
Slide 3: Safe Harbour
SAFE HARBOUR This investor presentation has been prepared by Clean Science and Technology Limited (“CSTL”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered o
Slide 4: Q2 FY 2023 & H1 FY 2023 Update
Q2 FY 2023 & H1 FY 2023 Update
Slide 5: Q2 FY23 Update
Q2 FY23 UPDATE Revenue growth intact; EBITDA margins stabilized on Q-o-Q basis but input prices continue to remain volatile 2x revenue over last 2 years 113 140 125 134 146 153 181 205 234 248 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 50.40% 50.60% 50.30% 52.90%
Slide 6: Q2 FY23 and H1 FY23 P&L Overview
Q2 FY23 and H1 FY23 P&L OVERVIEW Sustained revenue growth and meaningful profitability margins; input prices continue to remain short term concern P&L (INR Crore) Q2 FY 2023 Q1 FY 2023 Q-o-Q (%) Q2 FY 2022 Y-o-Y (%) H1 FY 2023 H1 FY 2022 Y-o-Y (%) Sale of products 245.0 232.0 6% 151.7 62% 477.0 296.
Slide 7: H1 FY 2023: Balance Sheet Summary
H1 FY 2023: BALANCE SHEET SUMMARY Debt free balance sheet with cash surplus of ~INR 235 Crores; strong return ratios As at As at In INR Crore 30-September-2022 31-March-2022 Assets Non-current assets Fixed Assets 323.7 292.3 Capital work-in-progress 41.8 44.1 Right of use asset 2.9 2.9 Other non-cur
Slide 8: Revenue Profile – H1 FY 2023
REVENUE PROFILE – H1 FY 2023 Strong revenue growth across all segments and geographies REVENUE MIX BY SEGMENT (INR Cr.) REVENUE MIX BY GEOGRAPHY 319 217 97 41 53 33 6% 7% 15% 15% 35% 38% H1 FY23 15% H1 FY22 15% 29% 25% Performance Pharma & Agro FMCG Chemicals Intermediates Chemicals H1 FY 2023 H1 FY
Slide 9: Corporate presentation
Corporate presentation
Slide 10: Clean Science and Technology at a Glance
CLEAN SCIENCE AND TECHNOLOGY AT A GLANCE A brief Introduction about the Company Among the few global organisations focused on developing ingenious technologies with unique, innovative, sustainable, and cost-effective catalytic manufacturing processes Globally, among the largest manufacturers of
Slide 11: Company Evolution
COMPANY EVOLUTION Continuous R&D and Innovation has led to new product launches on a consistent basis YEAR 2006 2009 2011 2014 2018 2020 2021 2022 REVENUES (INR Crore) - 1 19 120 241 419 512 685 Commercialized plant to Commercialized manufacture P-BQ and TBHQ 2022 unique vapour phase route to ma
Slide 12: Diversified Product Profile Serving Critical End-User Industries
DIVERSIFIED PRODUCT PROFILE SERVING CRITICAL END-USER INDUSTRIES Largest capacity in the world for our flagship products PERFORMANCE PHARMA AND AGRO FMCG CHEMICALS INTERMEDIATES CHEMICALS MEHQ (Monomethyl Ether of Hydroquinone) Guaiacol 4-MAP (4-Methoxy Acetophenone) Used as polymerization inhibit
Slide 13: Key Differentiators That Add Value
KEY DIFFERENTIATORS THAT ADD VALUE Unique benefits that set our business apart from competition INNOVATION GLOBAL LEADERS PREFERRED PARTNER STATE-OF-THE-ART Strategic process innovation Among the largest OF CHOICE Multiple, automated and new product producers globally of Strong and long term manufac
Slide 14: Steadfast Focus on Research & Development
STEADFAST FOCUS ON RESEARCH & DEVELOPMENT Pioneered commercialization of catalytic reactions Research and Development team’s focus areas Enhance our existing catalyst Develop products with high demand Expand product portfolio in the 1 systems to further optimize yield 2 performance chemical segment
Slide 15: Cohesive and Technocrat Promoters
COHESIVE AND TECHNOCRAT PROMOTERS Strong visibility on longevity of Promoters’ engagement in the business Over 25 years of work experience in Over 15 years of experience in the the chemical industry. chemical industry. Previously worked as an Executive Director at Mangalam Drugs and Bachelor of Chem
Slide 16: Robust Corporate Governance
ROBUST CORPORATE GOVERNANCE Distinguished Board of Directors and reputed financial market participants underscore sound governance PROFILE OF NON-EXECUTIVE, INDEPENDENT DIRECTORS ON THE BOARD PRADEEP RATHI PROF. G. D. YADAV Sanjay Kothari Chairman and Non-Executive Director Non-Executive, Independen
Slide 17: Continued Commitment Towards Sustainability and ESG
CONTINUED COMMITMENT TOWARDS SUSTAINABILITY AND ESG Sustainability and ESG initiatives are embedded in our long term growth strategy ENVIRONMENT EMPATHY (E) SOCIAL RESPONSIBILITY (S) CORPORATE GOVERNANCE (G) Utilize resources efficiently, reduce waste Total contribution towards CSR activities
Slide 18: Advanced Manufacturing Facilities Designed by In-House Engineering Team
ADVANCED MANUFACTURING FACILITIES DESIGNED BY IN-HOUSE ENGINEERING TEAM 3 independent functional units with dedicated lines for each product UNIT 1 Nil plant closure notice received from any 7 plants pollution control board Total area – 30,000 sq.m All Units are ISO 9001, ISO 14001 and ISO 45001 cer
Slide 19: Strong Financials
STRONG FINANCIALS Resilient performance demonstrated over business cycles maintaining a debt free balance sheet REVENUE EBITDA & EBITDA% PAT & PAT% CAGR of 30% EBITDA CAGR of 42% PAT CAGR of 47% 243 393 419 512 685 73 136 185 259 300 49 98 140 198 229 44% 33% 51% 39% 44% 33% 35% 20% 25% 30% FY 2018
Slide 20: Our Key Growth Drivers
KEY GROWTH LEVERS Strategic initiatives and investments aimed at long term sustainable growth FOCUS ON ESG SIGNIFICANT ANDSUSTAINABILITY GREENFIELD CAPEX Capitalise on our core philosophy Planned capex of Rs. 300 crore+ of clean and green chemistry to over next two years for address opportunities ar
Slide 21: Thank You
THANK YOU For further information, please contact: SWAPNIL MORAY Investor Relations Email: swapnil@cleanscience.co.in Clean Science and Technology Limited Website: https://www.cleanscience.co.in/
Clean Science and Technology — Q2 FY2023 Earnings Presentation on 6ix